Search

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 3-19
Author(s): H. Rumpold, G. Webersinke

Towards Cure of CML: Why We Need to Know More About CML Stem Cells?

Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 3 Year: 2009 Page: 224-236
Author(s): Jeroen J.W.M. Janssen, Gerrit J. Schuurhuis, Monique Terwijn, Gerrit J. Ossenkoppele

Last Findings on Dual Inhibitors of Abl and Src Tyrosine-Kinases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 2 Year: 2007 Page: 191-201
Author(s): S. Schenone, F. Manetti, M. Botta

Current Treatment Concepts of CML

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 31-43
Author(s): A. A. Leitner, A. Hochhaus, M. C. Muller

in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 58-68
Author(s): Gabriella Marfe, Carla Di Stefano

Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay

Journal: Current Drug Targets
Volume: 18 Issue: 4 Year: 2017 Page: 377-388
Author(s): Danilo Perrotti,Giovannino Silvestri,Lorenzo Stramucci,Justine Yu,Rossana Trotta

Is Going for Cure in CML Targeting Aberrant Glycogen Synthase Kinase 3β?

Journal: Current Drug Targets
Volume: 18 Issue: 4 Year: 2017 Page: 396-404
Author(s): Concetta Saponaro,Michele Maffia,Nicola Di Renzo,Addolorata Maria Luce Coluccia

Inhibition of Abl Kinases by Intramolecular and Intermolecular Interactions: A Lesson from Structure Studies and CML Therapy

Journal: Current Enzyme Inhibition
Volume: 2 Issue: 2 Year: 2006 Page: 135-146
Author(s): Baojie Li

Novel Purine Nucleoside Analogues for Hematological Malignancies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 123-136
Author(s): Anna Korycka, Ewa Lech-Maranda, Tadeusz Robak

Novel Purine Nucleoside Analogues for Hematological Malignancies

Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Anna Korycka, Ewa Lech-Maranda, Tadeusz Robak
Doi: 10.2174/978160805161811001010219